GO IN VIVO
DEAD

Serial Number

85555680

Owner

BAY GENOMICS, LLC

First Use Date

Mar 1, 2015

Filing Date

Feb 28, 2012

Add to watchlist:

No watchlists yet
View on USPTO

GO IN VIVO Trademark

Serial Number: 85555680 • Registration: 4859983

GO IN VIVO is a trademark filed by BAY GENOMICS, LLC on February 28, 2012. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

BAY GENOMICS, LLC (3 trademarks)

1440 4TH ST STE C
BERKELEY, CA 94710

Entity Type: 16

Spiral Genomics, LLC (2 trademarks)

Suite 120
Berkeley, CA 94710

Entity Type: 16

SPIRAL DEVICES, LLC (2 trademarks)

1440 4th St
BERKELEY, CA 94710

Entity Type: 16

Trademark Details

Filing Date

February 28, 2012

Registration Date

November 24, 2015

First Use Anywhere

March 1, 2015

First Use in Commerce

March 1, 2015

Published for Opposition

February 5, 2013

Cancellation Date

June 5, 2026

Goods & Services

[ Light-based medical devices, namely, a light emitting diode (LED) device for increasing the human body's own production of collagen; Medical apparatus for treating congestive heart failure; Medical device and surgical instrument for use in diagnosis and surgery of the gastro-intestinal tract; Medical device for accessing subcutaneous structures of the human body for the purpose of administering medical treatment; Medical device for detecting cancer; Medical device for treating cancer; Medical device for treating lymphedema; Medical device, namely, a device for improving cardiac performance through aortic flow therapy; Medical device, namely, a device for measuring arterial blood flow in the eye; Medical device, namely, a remote manipulation system consisting of a robotic arm, knob, deflection lever, and buttons, to facilitate remote catheterizations; Medical device, namely, a tele-robotic system consisting of a motorized catheter positioner having rotational and translational movement capability and a tele-robotic controller with rotation, translation and deflection control buttons, to facilitate remote catheterizations; Medical devices and apparatus, namely, ultrasound imaging apparatus, scanners and needle guides, and parts and fittings therefor; Medical devices, namely, devices for spinal disc repair in the nature of an apparatus used in spinal disc repair procedures; Medical devices, namely, devices for spinal disc repair in the nature of spinal disc implants made from artificial substances; Medical devices, namely, hand-held motorized, vibrating devices used near injection sites for reducing pain during hypodermic needle injections; Medical devices, namely, intravascular implants comprised of artificial material; Medical devices, namely, minimally invasive devices for abdominal aortic aneurysms repair; Medical devices, namely, minimally invasive neurovascular devices for the treatment of neurological conditions; Medical devices, namely, myocardial ischemia scanning devices; Medical devices, namely, surgical devices that facilitate the identification, separation or ablation of biologic tissues ]

Genetic testing for medical purposes; Genetic testing of animals

[ Assays and reagents for use in genetic research; Assays for research purposes; Biochemicals, namely, precursors for in vitro genetic engineering use; Genetic identity tests comprised of reagents ] [ ; Paternity identity tests comprised of reagents ]

Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Genetic mapping for scientific purposes; Genetic testing of laboratory animals for research purposes; [ Providing a website featuring information about investigational medical devices, diagnostic and drugs; ] Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research in the field of genetics and genetic engineering; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy

Computer software for scientific analysis of genetic sequences; Electrical equipment for the genetic modification of cells for research purposes; Laboratory devices for detecting genetic sequences

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jun 5, 2026 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Nov 24, 2024 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Nov 18, 2022 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Nov 18, 2022 C15P
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Nov 17, 2022 EROP
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
May 17, 2022 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 17, 2022 APRE
TEAS SECTION 8 & 15 RECEIVED
Nov 24, 2021 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Nov 24, 2020 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Feb 3, 2016 ASGN
REGISTERED-PRINCIPAL REGISTER
Nov 24, 2015 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 17, 2015 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 16, 2015 CNPR
EXAMINER'S AMENDMENT ENTERED
Oct 16, 2015 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 16, 2015 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 16, 2015 GNEA
SU-EXAMINER'S AMENDMENT WRITTEN
Oct 16, 2015 SNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 20, 2015 GNRN
NON-FINAL ACTION E-MAILED
Mar 20, 2015 GNRT
SU - NON-FINAL ACTION - WRITTEN
Mar 20, 2015 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Mar 18, 2015 SUPC
USE AMENDMENT FILED
Mar 12, 2015 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 12, 2015 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 4, 2014 EXRA
SOU EXTENSION 3 GRANTED
Oct 3, 2014 EX3G
SOU EXTENSION 3 FILED
Oct 1, 2014 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 1, 2014 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 8, 2014 EXRA
SOU EXTENSION 2 GRANTED
Apr 7, 2014 EX2G
SOU EXTENSION 2 FILED
Apr 1, 2014 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 1, 2014 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 5, 2013 EXRA
SOU EXTENSION 1 GRANTED
Nov 2, 2013 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 28, 2013 AITU
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Oct 2, 2013 ASGN
SOU EXTENSION 1 FILED
Oct 1, 2013 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 1, 2013 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 1, 2013 TCCA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 2, 2013 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 5, 2013 NPUB
PUBLISHED FOR OPPOSITION
Feb 5, 2013 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 16, 2013 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Dec 29, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 24, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 19, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2012 CRFA
ASSIGNED TO LIE
Dec 11, 2012 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 8, 2012 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 8, 2012 TCCA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 8, 2012 GNRN
NON-FINAL ACTION E-MAILED
Jun 8, 2012 GNRT
NON-FINAL ACTION WRITTEN
Jun 8, 2012 CNRT
ASSIGNED TO EXAMINER
Jun 7, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 7, 2012 NWOS
NEW APPLICATION ENTERED
Mar 2, 2012 NWAP